BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5598901)

  • 21. [Protein synthesis induced by vitamin K deficiency].
    Hemker HC
    Nouv Rev Fr Hematol; 1970; 10(5):645-51. PubMed ID: 4250287
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rodenticide effect of warfarin. 1. Effect on blood coagulation].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 May; 24(5):802-6. PubMed ID: 4408104
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (Cl-K), acenocoumarol, brodifacoum and difenacoum in the rabbit [proceedings].
    Breckenridge AM; Leck JB; Park BK; Serlin MJ; Wilson A
    Br J Pharmacol; 1978 Nov; 64(3):399P. PubMed ID: 719257
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulant resistance: an unusual case.
    Barnett DB; Hancock BW
    Br Med J; 1975 Mar; 1(5958):608-9. PubMed ID: 1125626
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of coumadin on the prothrombin (factor II) coagulation pathway in man: relationship between antigen and activity levels.
    Lox CD; Maciulla GJ; Heine MW; Messiha FS; Corrigan JJ
    Proc West Pharmacol Soc; 1978; 21():237-9. PubMed ID: 693503
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the interaction of warfarin and clofibrate in man.
    O'Reilly RA; Sahud MA; Robinson AJ
    Thromb Diath Haemorrh; 1972 Apr; 27(2):309-18. PubMed ID: 4340370
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors V and VII anticoagulant activities in the salivary glands of feeding Dermacentor andersoni ticks.
    Gordon JR; Allen JR
    J Parasitol; 1991 Feb; 77(1):167-70. PubMed ID: 1992089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic study of human prothrombin and thrombin].
    Josso F; Lavergne JM; Weilland C; Soulier JP
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):311-24. PubMed ID: 4173212
    [No Abstract]   [Full Text] [Related]  

  • 31. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
    Girolami A; Patrassi O; Cella G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):463-70. PubMed ID: 72033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent influence of acetylsalicyclic acid on platelet functions and plasmatic coagulation factors.
    Loew D; Vinazzer H
    Haemostasis; 1976; 5(4):239-49. PubMed ID: 1002006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VII during warfarin treatment.
    Howarth DJ; Brozović M; Stirling Y; Reed M
    Scand J Haematol; 1974; 12(5):346-54. PubMed ID: 4859330
    [No Abstract]   [Full Text] [Related]  

  • 36. Misleading results in studying pharmacodynamic interaction with oral anticoagulants.
    de Feo G; Lisciani R; Del Vecchio A; Orticelli G; Valeri P; Noli G; Mazzanti G
    Boll Chim Farm; 1990 Apr; 129(4):166-8. PubMed ID: 2245005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anticoagulant effect of phosphatidylserine].
    Tersenov OA; Chabanov MK
    Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for an essential role of tissue factor dependent blood coagulation in the pathogenesis of the local Shwartzman reaction.
    Zivelin A; Rao LV; Rapaport SI
    Blood Cells Mol Dis; 1995; 21(1):9-19. PubMed ID: 7655863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 40. [Toxicity of warfarin and its effect on blood coagulation in rat and mice].
    Niedner R; Kayser M; Reuter N; Meyer F; Perkow W
    Arzneimittelforschung; 1973 Jan; 23(1):102. PubMed ID: 4740693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.